Denali Therapeutics welcomes Nancy Thornberry to its Board of Directors

– USA, CA –  Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced the appointment of Nancy Thornberry to its Board of Directors, effective January 8, 2021.…

Beam Therapeutics welcomes Kate Walsh to its Board of Directors

– USA, MA –  Beam Therapeutics Inc. (NASDAQ: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Kate Walsh, president, and CEO of the Boston Medical Center (BMC) to its board of directors.…